Takeda (TSE:4502/NYSE:TAK) today announced positive data from the pivotal Phase 3 KEPLER trial, which demonstrated that ENTYVIO® (vedolizumab) can offer the possibility of clinical remission for ...

PROSERA Study Overview and Baseline Characteristics ...

Wildlife faults often produce electrical signatures similar to direct conductor contact, making diagnosis challenging without ...

A man convicted of fatally shooting a police officer with his own service weapon during a traffic stop is set to be executed in Florida.

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced that tomorrow it will ...

Rushcliffe Borough Council’s Cabinet is set to decide whether to formally adopt a long-awaited planning framework intended to guide development of the major ...

VDPHL01 has the potential to be the first and only extended-release oral minoxidil for women and men with pattern hair loss, a condition affecting an estimated 30 million women and 50 million men in ...

Add Yahoo as a preferred source to see more of our stories on Google. TEMPLE HILLS, MD — A Prince George's man has been sentenced to federal prison in connection to two cases - one involving drug ...

Restoration work is underway to return Slagle Run in Hanover to its natural floodplain, improving both wildlife habitat and ...

Although AI has introduced a new threat in the world of payments fraud, it has also emerged as the analytical backbone of next-generation fraud mitigation systems.

This marks the completion of enrollment of all male Phase 3 studies of VDPHL01 in pattern hair loss, with approximately 1,000 male patients enrolled across studies Topline data from initial '302' ...